Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
Status: Recruiting
Location: See all (36) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Healthy Volunteers: f
View:
• IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia.
• IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.
Locations
Other Locations
Belgium
AZ Sint-Lucas
RECRUITING
Ghent
UZ Gasthuisberg
RECRUITING
Leuven
Canada
Queen Elizabeth II Health Sciences Center
RECRUITING
Halifax
Germany
University Berlin, Charite Virchow Standort, Wedding
RECRUITING
Berlin
Uniklinik Köln
RECRUITING
Cologne
Universitaetsklinikum Dusseldorf
RECRUITING
Düsseldorf
Universitaetsklinikum Freiburg
RECRUITING
Freiburg Im Breisgau
Universitaetsklinik Eppendorf
RECRUITING
Hamburg
St. Barbara-Klinik Hamm-Heessen
COMPLETED
Hamm
Medizinische Hochschule Hannover MHH
RECRUITING
Hanover
Universitatsklinikum Campus Kiel
RECRUITING
Kiel
Johannes Gutenberg Universitaet Mainz
TERMINATED
Mainz
Universitaetsklinikum Giessen und Marburg GmbH
RECRUITING
Marburg
Evangelisches Krankenhaus Oldenburg
WITHDRAWN
Oldenburg
Universitaetsklinikum Wuerzburg
RECRUITING
Würzburg
Hungary
Medical School of University PECS
RECRUITING
Pécs
Israel
Hadassah Hebrew University Medical Center
COMPLETED
Jerusalem
Italy
Azienda Ospedaliero-Universitaria di Ferrara
COMPLETED
Ferrara
Ospedale Dell Angelo
RECRUITING
Mestre
Policlinico Universitario Agostino Gemelli
COMPLETED
Rome
Osp. S. Maria Della Misericordia
TERMINATED
Udine
Netherlands
Haga Ziekenhuis locatie Leyweg
RECRUITING
The Hague
Poland
10 Military Clinical Hospital Bydgoszcz
TERMINATED
Bydgoszcz
Wojewodzki Szpital Dzieciecy Jozefa Brudzinskiego (Childrens Hospital Bydgoszcz)
TERMINATED
Bydgoszcz
Podmiot Leczniczy Copernicus Sp. z o.o.
TERMINATED
Gdansk
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie
TERMINATED
Warsaw
Republic of Korea
St. Mary's Hospital Incheon
ACTIVE_NOT_RECRUITING
Incheon
Russian Federation
National Scientific Center of Neurosurgery N.N. Burdenko
TERMINATED
Moscow
Spain
Hospital Clinic de Barcelona
COMPLETED
Barcelona
University Hospital Virgen Arrixaca
WITHDRAWN
El Palmar
Centro Especial Ramon y Cajal
COMPLETED
Madrid
Hospital General De Asturias
WITHDRAWN
Oviedo
United Kingdom
Southmead Hospital Bristol
WITHDRAWN
Bristol
Queen Elizabeth University Hospital
COMPLETED
Glasgow
Charing Cross Hospital
RECRUITING
London
Royal Victoria Infirmary
RECRUITING
Newcastle Upon Tyne
Contact Information
Primary
Stephanie Delvaux
BSNClinicalTrials@bsci.com
855-213-9890
Backup
Diane Keesey
BSNClinicalTrials@bsci.com
855-213-9890
Time Frame
Start Date: 2016-03-07
Estimated Completion Date: 2030-12
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation